BIOFOUNDRY FOR BIOPHARMACEUTICAL CELL BANKS
"Early Development and Scale-up Proof of Concept (PoC) for Biotherapeutics and Vaccines"

Contacts Us:

icon-phone-blue
24/7 Support +91 ************
icon-envelope-blue
icon-location-blue
Our Locati0n Chandigarh, India

Follow Us:

  • icon-dark-facebook
  • icon-dark-twitter
  • icon-dark-dribbble
  • icon-dark-instagram

Add to cart

No Items in Cart

Design and Development of Recombinant Protein Expression Vectors

  • Home
  • /
  • Design and Development of Recombinant Protein Expression Vectors

Recombinant protein expression vectors are essential tools in biotechnology and pharmaceutical industries for producing therapeutic proteins, enzymes, antibodies, and other biologically active molecules. These vectors are plasmid or viral constructs that facilitate the expression of a gene of interest in a suitable host organism (bacteria, yeast, insect, or mammalian cells). The design and development of these vectors involve several key considerations to ensure high-yield, stable, and functional protein production.

Overview of processes involved in design and development of recombinant protein expression vectors

Before designing the expression vector, the choice of the host organism is critical. Different hosts have varying capabilities to express and modify proteins. Common host organisms and their associated benefits are:

  • Bacterial Systems (e.g., E. coli):
    • Ideal for simple, high-yield protein expression.
    • Fast growth and easy genetic manipulation.
    • Limited capability for post-translational modifications (PTMs).

  • Yeast Systems (e.g., Pichia pastoris, Saccharomyces cerevisiae):
    • Suitable for proteins that require some PTMs (e.g., glycosylation).
    • Can be grown in large-scale fermenters.

The gene encoding the target protein must be prepared for insertion into the expression vector. This involves:

  • Codon Optimization:
    • The gene's codon sequence is often optimized for the host cell's codon usage to ensure efficient translation.
    • This is particularly crucial for bacterial systems like E. coli, which have different codon preferences than mammalian cells.

  • Gene Synthesis:
    • If the gene is not readily available, it can be synthesized de novo using the known sequence, or obtained via cDNA synthesis from mRNA.

  • Adding Functional Elements:
    • Additional sequences may be incorporated into the gene, such as signal peptides (for secretion), fusion tags (e.g., His-tag, GST-tag), or affinity purification sequences.

A typical recombinant expression vector contains several essential elements:

Promoter

  • Choice of Promoter: The promoter controls the initiation of transcription and is a crucial part of the vector design.
    • Constitutive Promoters: These promoters (e.g., T7 for E. coli, CMV for mammalian cells) drive continuous expression.
    • Inducible Promoters: Inducible promoters (e.g., lac, TET, or AraC) allow the user to control when the protein is expressed by adding an inducer (e.g., IPTG, tetracycline, arabinose).
    • Host-Specific Promoters: Some vectors use promoters specific to the host cell system (e.g., PGK for mammalian cells, AOX1 for yeast).

Selectable Marker

  • Antibiotic Resistance Genes: These are used to select cells that have successfully incorporated the vector. Common markers include ampicillin resistance in E. coli (e.g., bla gene) and neomycin resistance in mammalian cells (e.g., neo gene).
  • Positive Selection Markers: In mammalian systems, a marker such as puromycin or hygromycin may be used to select stable transfectants.

Replication Origin

  • Origin of Replication: The vector must have an origin of replication that is compatible with the host cell. For E. coli, a common replication origin is pBR322, whereas mammalian cells require a different origin, such as the SV40 origin.

Multiple Cloning Site (MCS)

  • The MCS is a short DNA sequence that contains several unique restriction enzyme sites. It provides a region to insert the gene of interest. The MCS is located near the promoter, enabling easy ligation of the GOI.

Tag Sequences (Optional)

  • Tags: Fusion tags are often added to the recombinant protein to simplify purification, detection, or localization.
    • Common tags include His-tags (for affinity chromatography), GFP (Green Fluorescent Protein) for visualization, and FLAG tags for antibody-based detection.

  • Restriction Enzyme Digestion and Ligation: The gene of interest (GOI) is typically inserted into the vector using restriction enzymes that cut both the plasmid and the gene at specific sites. DNA ligase is then used to join the plasmid and gene.
  • Gateway Cloning or Gibson Assembly: Alternative cloning strategies that offer flexibility and reduce time by eliminating the need for restriction enzymes.

Once the expression vector is constructed, it must be introduced into the host cell. This is done through:

  • Transformation: Introducing the recombinant vector into bacteria (typically E. coli) using heat shock or electroporation.
  • Transfection: Introducing the recombinant vector into mammalian or insect cells, typically by chemical transfection (e.g., lipofection), electroporation, or viral vectors (e.g., lentivirus or baculovirus).
  • Selection: Cells that successfully take up the plasmid are selected using the selectable markers incorporated into the vector.

After transfection or transformation, the cells are cultured and screened for successful expression of the recombinant protein. Screening techniques may include:

  • Colony PCR or Restriction Digest: To confirm the presence of the gene in the vector.
  • Western Blotting or ELISA: To detect and quantify protein expression.
  • Functional Assays: To ensure the recombinant protein is biologically active.

After successful cloning, the next challenge is optimizing the expression of the recombinant protein. Key factors include:

  • Induction Conditions: For bacterial systems, factors such as induction temperature, IPTG concentration, and time can be optimized.
  • Host Strain Optimization: Different strains of E. coli (e.g., BL21, Rosetta, or C41) may offer advantages for certain types of protein expression (e.g., solubility or high yield).
  • Culture Conditions: For mammalian cells, media, temperature, and serum conditions are optimized for the highest protein yield and correct folding.

Once high levels of the recombinant protein are expressed, it needs to be purified. Common purification techniques depend on the tag and characteristics of the protein:

  • Affinity Chromatography: Using His-tags (Ni-NTA column) or other tags for purification.
  • Size Exclusion Chromatography: To separate proteins by size.
  • Ion Exchange Chromatography: To separate proteins based on charge.

In eukaryotic expression systems, recombinant proteins may undergo PTMs, including glycosylation, phosphorylation, and disulfide bond formation, which are important for functional activity. This must be monitored and verified.